Self-reported sleep duration and napping, cardiac risk factors and markers of subclinical vascular disease: cross-sectional study in older men

BMJ Open. 2017 Jul 2;7(6):e016396. doi: 10.1136/bmjopen-2017-016396.

Abstract

Studyobjectives: Daytime sleep has been associated with increased risk of cardiovascular disease and heart failure (HF), but the mechanisms remain unclear. We have investigated the association between daytime and night-time sleep patterns and cardiovascular risk markers in older adults including cardiac markers and subclinical markers of atherosclerosis (arterial stiffness and carotid intima-media thickness (CIMT)).

Methods: Cross-sectional study of 1722 surviving men aged 71-92 examined in 2010-2012 across 24 British towns from a prospective study initiated in 1978-1980. Participants completed a questionnaire and were invited for a physical examination. Men with a history of heart attack or HF (n=251) were excluded from the analysis.

Results: Self-reported daytime sleep duration was associated with higher fasting glucose and insulin levels (p=0.02 and p=0.01, respectively) even after adjustment for age, body mass index, physical activity and social class. Compared with those with no daytime sleep, men with daytime sleep >1 hour, defined as excessive daytime sleepiness (EDS), had a higher risk of raised N-terminal pro-brain natriuretic peptide of ≥400 pg/mL, the diagnostic threshold for HF (OR (95% CI)=1.88 (1.15 to 3.1)), higher mean troponin, reduced lung function (forced expiratory volume in 1 s) and elevated von Willebrand factor, a marker of endothelial dysfunction. However, EDS was unrelated to CIMT and arterial stiffness. By contrast, night-time sleep was only associated with HbA1c (short or long sleep) and arterial stiffness (short sleep).

Conclusions: Daytime sleep duration of >1 hour may be an early indicator of HF.

Keywords: cardiac function; sleep patterns; subclinical atherosclerosis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aged, 80 and over
  • Asymptomatic Diseases
  • Atherosclerosis / complications
  • Atherosclerosis / diagnostic imaging
  • Atherosclerosis / physiopathology*
  • Biomarkers / blood
  • Blood Glucose / metabolism*
  • Carotid Intima-Media Thickness
  • Cross-Sectional Studies
  • Disorders of Excessive Somnolence / blood*
  • Disorders of Excessive Somnolence / complications
  • Disorders of Excessive Somnolence / physiopathology
  • Forced Expiratory Volume
  • Glycated Hemoglobin / metabolism*
  • Heart Failure / diagnosis
  • Heart Failure / physiopathology
  • Humans
  • Insulin / blood*
  • Male
  • Natriuretic Peptide, Brain / blood
  • Peptide Fragments / blood
  • Pulse Wave Analysis
  • Risk Factors
  • Self Report
  • Sleep / physiology*
  • Time Factors
  • Troponin / blood
  • Vascular Stiffness
  • von Willebrand Factor / metabolism

Substances

  • Biomarkers
  • Blood Glucose
  • Glycated Hemoglobin A
  • Insulin
  • Peptide Fragments
  • Troponin
  • hemoglobin A1c protein, human
  • pro-brain natriuretic peptide (1-76)
  • von Willebrand Factor
  • Natriuretic Peptide, Brain